Seiko Otokozawa - Concepedia

Concepedia

Author

Seiko Otokozawa

Tufts University

Also Known As

S Otokozawa, S. Otokozawa, SEIKO OTOKOZAWA, Seiko Otokozawa

48

Publications

3.4K

Citations

21

H-Index

35

Concepts

All Affiliations

Tufts University Sapporo Medical University Boston University Kyushu University Hospital Louisville Metabolic and Atherosclerosis Research Center

SO

About

Seiko Otokozawa is an author at Tufts University specializing in metabolic syndrome, medicine, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	662
2	Diabetes	7	7	388
3	Public Health	6	6	239
4	Health Sciences	4	4	166
5	Biochemistry	1	1	26

Seiko Otokozawa

×

27

Publications

3.4K

Citations

21

H-Index

	Year	Citations
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans Kimber L. Stanhope, Jean Marc Schwarz, Nancy L. Keim, Journal of Clinical Investigation	2009	1.7K
Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect Daisuke Kobayashi, Kei Kondo, Nobuyuki Uehara, Antimicrobial Agents and Chemotherapy	2002	333
Small Dense LDL Cholesterol and Coronary Heart Disease: Results from the Framingham Offspring Study Masumi Ai, Seiko Otokozawa, Bela F. Asztalos, Clinical Chemistry	2010	180
Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS) Norihiro Furusyo, Toshiki Koga, M. Ai, Diabetologia Metabolic SyndromeDiabetes EpidemiologyOkinawa Population StudyGlycated AlbuminDiabetes	2011	155
Extended-Release Niacin Alters the Metabolism of Plasma Apolipoprotein (Apo) A-I and ApoB-Containing Lipoproteins Stefania Lamon‐Fava, Margaret R. Diffenderfer, P. Hugh R. Barrett, Arteriosclerosis Thrombosis and Vascular Biology	2008	147
Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers Thomas M. van Himbergen, Nirupa R. Matthan, Nancy Resteghini, Journal of Lipid Research	2008	109
Adiponectin: An independent risk factor for coronary heart disease in men in the Framingham offspring Study Masumi Ai, Seiko Otokozawa, Bela F. Asztalos, Atherosclerosis Metabolic SyndromeCardiovascular EpidemiologyCardiovascular DiseaseFramingham Offspring StudyMetabolic Disorder	2011	90
Effects of Maximal Atorvastatin and Rosuvastatin Treatment on Markers of Glucose Homeostasis and Inflammation Nuntakorn Thongtang, Masumi Ai, Seiko Otokozawa, The American Journal of Cardiology InflammationMetabolic SyndromeMaximal AtorvastatinCardiovascular DiseaseMicrovascular Dysfunction	2011	67
Effects of Maximal Doses of Atorvastatin Versus Rosuvastatin on Small Dense Low-Density Lipoprotein Cholesterol Levels Masumi Ai, Seiko Otokozawa, Bela F. Asztalos, The American Journal of Cardiology Cardiovascular DiseaseMedicineAtorvastatin Versus RosuvastatinHyperlipidemiaLipoprotein Metabolism	2007	60
Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects Seiko Otokozawa, Masumi Ai, Margaret R. Diffenderfer, Metabolism ObesityMetabolic SyndromeHyperlipidemic SubjectsCardiovascular DiseasePhysiology	2009	56

Page 1